Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial 2019-06-12 02:45
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging 2019-06-12 02:26
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging 2019-06-11 21:46
TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry 2019-06-11 08:00
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device 2019-06-10 21:00
Collaborative Medicinal Development, LLC Reports that Lead Drug Shows Dose-Dependent Improvement in Parkinson's Disease 2019-06-10 20:00
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions 2019-06-10 16:28
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib 2019-06-10 09:30
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks 2019-06-08 23:45
ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic 2019-06-08 07:01
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC 2019-06-05 19:56
Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO 2019-06-05 08:00
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer 2019-06-04 21:00
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma 2019-06-04 08:00
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma 2019-06-04 08:00
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC) 2019-06-04 08:00
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO 2019-06-04 07:00
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa 2019-06-04 06:39
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations 2019-06-04 02:16
Frost & Sullivan Publishes Q1 Update on Kadimastem 2019-06-03 21:24
1 291 292 293 294 295 377